Ashwagandha: KSM-66 vs Sensoril — Which Extract Is Superior?

The short answer before the long one

KSM-66 and Sensoril are not two names for the same thing. They are two different raw materials made from the same plant (Withania somnifera) by different methods, and their clinical track records are very unequal. If you want ashwagandha for training, recovery, strength and general stress tolerance, KSM-66 is the sensible pick - simply because most of the randomised human trials were run on that specific extract. If you want a low-dose evening calming option, Sensoril is theoretically the logical choice, but you will not find it on a shelf in Estonia.

That is the most useful sentence in this article: in Estonia the real decision is not "KSM-66 vs Sensoril". It is "KSM-66 vs an unbranded root extract". Sensoril-labelled products essentially do not circulate on our market, and if someone recommends one to you, the next step is usually ordering from outside Estonia with shipping cost and lead time that destroys the whole price calculation. So below we deal with the three options that actually exist: branded KSM-66, a standardised but unbranded root extract, and plain milled root powder.

What these two raw materials actually are

KSM-66 is a raw material from the Indian company Ixoreal Biomed, made from ashwagandha root only. The producer uses a water-based extraction with no alcohol or other organic solvents in the finished material, and typically standardises to at least 5% withanolides. The dose used in trials is high: usually 300 mg twice daily, 600 mg in total.

Sensoril is a raw material from the US company Natreon and it is made from root and leaf. The leaf carries a different withanolide profile, notably more withaferin A, which is a far more active and cytotoxic molecule in the lab than the withanosides that dominate the root. Standardisation is higher - at least 10% withanolide glycosides - so the daily dose is smaller, typically 125-250 mg.

Two things follow. First, comparing the milligram number on two jars tells you nothing when the standardisation percentage differs twofold. Second, two products both labelled "ashwagandha extract" can contain biologically different mixtures. This is not pedantry - it is exactly why trial results on one raw material cannot simply be transferred to the other.

Where the difference comes from: root, leaf and withaferin A

The ayurvedic tradition uses the root. The leaf is cheaper biomass and yields a higher withanolide content per unit of weight, which is logical from a manufacturer's point of view: less raw material, smaller capsule, bigger number on the label. Biologically, though, it is a different profile, not just a more concentrated version of the same thing.

In practice, leaf-containing extracts tend to be more sedating and more often associated with gastrointestinal complaints once the dose climbs. Root-based KSM-66 is generally well tolerated at the large doses used in trials, and it is that type of material that was used in the strength and performance studies. If your goal is training recovery, "a stronger molecule" is not an advantage but a risk that human trials have not answered well.

A third thing the label rarely tells you: whether the standardisation refers to withanolide glycosides or to total withanolides by HPLC. Those are different measurements and produce different percentages. If the jar simply says "5%" without qualification, that number is essentially unverifiable.

What the KSM-66 trials show

KSM-66's strongest result is cortisol and perceived stress. In a randomised, double-blind trial in 60 people, morning serum cortisol fell by roughly 28% on 600 mg per day over 60 days, alongside improvement on a perceived stress scale (Chandrasekhar et al., 2012). A later trial pointed the same way, with 240 mg per day lowering both perceived stress and cortisol in healthy, mildly stressed adults (Lopresti et al., 2019).

For smaller doses there is a dose-ranging study: 250 mg and 600 mg per day both improved stress scores and sleep quality, with 600 mg producing the larger effect more consistently (Salve et al., 2019). On sleep specifically, 300 mg twice daily improved sleep onset latency and sleep quality in people with insomnia and anxiety (Langade et al., 2019).

In the athletic context the most-cited work is an eight-week resistance-training study in which the KSM-66 group gained more bench press and leg extension strength and showed a larger testosterone increase than placebo (Wankhede et al., 2015). Be honest about that number: the subjects were untrained young men, the sample was small, and the absolute differences versus placebo were modest. This is not a testosterone pill. It is a moderate effect in people starting from zero.

Why Sensoril's evidence base is thinner

Sensoril's best-known human study, published in 2008 on chronic stress, appeared in a journal that PubMed does not index. That does not mean the study was not done - but it does mean you cannot track, check or cite it the way you can the KSM-66 trials. When two raw materials promise the same thing and one has a dozen indexed randomised trials while the other has a couple of hard-to-find ones, the choice is about the quality of the knowledge, not about marketing.

Sensoril's theoretical advantage is dose size. At 125-250 mg per day it fits into a smaller capsule and is more convenient for someone who does not want to take something twice a day. If your only goal is winding down in the evening, that argument exists. But among products actually sold in Estonia this option is practically absent, so the real decision is branded KSM-66 versus an unbranded extract.

Comparison table

Dosing and timing in practice

If you pick KSM-66, the dose consistent with the trials is 300 mg twice daily with food. Start with one dose per day in the first week - not as a safety requirement, but as a practical way to see whether it makes you drowsy. Roughly one in five people who try it describes daytime dullness; for them the whole dose works better in the evening.

Timing depends on what you are tracking. For sleep and evening wind-down: the whole dose 60-90 minutes before bed. For stress tolerance and training: morning and evening. Taking it before a session is not a pre-workout substitute - ashwagandha is not a stimulant and some people feel it blunts training intensity.

The effect is not immediate. Sleep-related changes are usually described within the first two weeks, while the cortisol and perceived-stress changes in the trials cited above were measured at eight weeks. If two months of consistent use changes nothing, it is not the right tool for you, and raising the dose further is not the answer.

Cycling is a popular recommendation with no good human data behind it. Most trials run 8-12 weeks, so there is simply no evidence on long-term continuous use. A reasonable conservative pattern is to use it through periods when your stress load is genuinely high and take a break when that passes.

What is actually available in Estonia and what it costs

All prices are at the time of writing and from the Estonian selection.

There are two good options with clear KSM-66 labelling. OstroVit KSM-66 Ashwagandha VEGE 120caps is 14.90 euros, which works out to about 12 cents per capsule - at two capsules a day that is roughly 25 cents a day and the jar lasts two months. MST Ashwagandha KSM66 60caps is 16.90 euros, about 28 cents per capsule; the 120-capsule pack of the same line at 23.90 euros is considerably cheaper per capsule, so the small jar only makes sense as a first trial.

On the unbranded side the price gap is large. OstroVit Ashwagandha VEGE 90tabs is 7.90 euros, under 9 cents per tablet, and the 200-tablet pack at 10.90 euros is cheaper still. ICONFIT Capsules Ashwagandha N90 is 13.90 euros and is an Estonian brand, usually bought because the name is already familiar. Beyond those, a BIOTECHUSA 60-capsule pack sells at 12.50 euros, an Olimp sport-line version at 12.90 euros, and NOW's 450 mg root capsules at 18.90 euros.

That last one is a good example of how not to compare. 450 mg of milled root is not the same as 300 mg of standardised extract - the extraction ratio means the extract capsule holds several times more active material than the same mass of powder. If you look only at the milligram number, the powder looks stronger and is in fact weaker. The full range sits in the ashwagandha category, and if you are buying it as part of a broader recovery plan it is worth reviewing vitamin complexes and creatine in the same basket - creatine's strength and recovery effect is far better documented than any adaptogen's.

How to read the label when there is no brand name

Most products on an Estonian shelf carry neither the KSM-66 nor the Sensoril logo. That does not make them bad - it means you have to check three things yourself.

First, whether the label says extract or powder, and whether an extraction ratio is given. "Ashwagandha root extract 300 mg, standardised to 5% withanolides" is a checkable sentence. "Ashwagandha 500 mg" is not.

Second, whether root or also leaf is used. If the leaf is not mentioned it is usually root, but leaf-containing extracts are a regulatorily sensitive topic in the Nordic market, so a serious manufacturer states it.

Third, what else is in the capsule. A vegetable capsule, magnesium stearate and rice flour are normal. If the formula adds five more "supporting" botanicals in microgram amounts, you are paying for marketing.

And one Estonian specific: food supplements are notified to the Health Board (Terviseamet) and their labelling may not carry claims about treating or preventing disease. That is why proper labels talk vaguely about wellbeing - it is a legal requirement, not an absence of evidence. At the same time it is worth knowing that some Nordic countries have restricted ashwagandha in food supplements on the basis of risk assessments, a useful reminder that this is a pharmacologically active plant rather than a vitamin.

Who should skip this

This is the section most comparisons leave out.

Skip it if you are pregnant or breastfeeding. Ashwagandha has traditionally been associated with miscarriage risk and no human trial justifies its use in pregnancy.

Skip it if you have an autoimmune condition, particularly a thyroid one. Ashwagandha can raise thyroid hormone levels, and people on levothyroxine have described their dose balance shifting. If a thyroid medication is in play, this is a conversation with a doctor, not a decision to make alone.

Skip it, or ask first, if you use sedatives, sleep medication, antidepressants or immunosuppressants - the additive sedative effect is real and it is not on the label.

Most important: ashwagandha has been linked to rare cases of liver injury. A case series from Iceland and the US Drug-Induced Liver Injury Network described jaundice and raised transaminases in people using ashwagandha supplements, mostly within a few months of starting (Bjornsson et al., 2020). Cases are rare and most resolved after stopping, but if you develop unusual fatigue, darker urine or yellowing skin, the right move is to stop and see a doctor rather than wait.

If you have existing liver disease, or drink regularly alongside medications that tax the liver, this is not a sensible first choice for you.

The eight-week test that gives you an answer

Ashwagandha's effect is subjective, which makes it easy for placebo to do the work. The only way to know whether it works for you is to measure something before you start.

Pick two numbers to track: for example minutes to fall asleep and a morning-wellbeing score from 1 to 10. Write them down for seven days before you start. Then take 600 mg of KSM-66 per day for eight weeks without changing your training plan, caffeine intake or bedtime at the same time - change three things at once and you will know nothing at the end.

After eight weeks, compare. If sleep onset is shorter and the morning score is up by at least two points, this is a tool for you and re-buying the jar is justified. If not, then 15 euros every two months is a cost with no reason to pay it.

Those same two numbers are also how you separate ashwagandha from magnesium, a frequent pairing in Estonian baskets. The combination is covered separately in ashwagandha and magnesium for sleep.

Where ashwagandha fits in the rest of your plan

Ashwagandha is a tool for cortisol and perceived stress. It does not fix a bad sleep routine, too much afternoon caffeine, or eight training sessions a week with no rest day. If those three are off, the first investment of money and time belongs there, not in a jar.

If you want to lower cortisol systematically there is a separate and more practical plan for it: see how to lower cortisol naturally. If your question is only about the form - capsule, powder, extract strength - that is written up in the best ashwagandha form.

A realistic expectation: moderate improvement in stress tolerance and sleep, a small strength effect as a beginner, nothing dramatic. For that money it is a good deal. Any promise that sounds better than this is marketing.

FAQ

Is KSM-66 always better than an unbranded extract?

Better documented - yes. Automatically stronger in your body - not proven. A branded raw material means a known extraction method and standardisation, which is precisely why trial results can be attributed to it at all. If the budget is tight, a standardised unbranded extract is a reasonable first attempt.

How long before I notice anything?

For sleep, usually 1-2 weeks; for perceived stress and cortisol, changes were measured at eight weeks (Chandrasekhar et al., 2012). If eight weeks changes nothing, raising the dose is not the fix.

Is 600 mg a day a lot?

It is the dose used in most KSM-66 trials and is generally well tolerated. A higher dose is not better studied and raises the chance of gastrointestinal complaints.

Does ashwagandha raise testosterone?

In untrained men a small increase was described over eight weeks alongside resistance training (Wankhede et al., 2015). In trained men with normal levels there is no basis to expect a meaningful change. Ashwagandha is not hormone replacement.

Can I take it with magnesium?

Yes, it is a common evening combination and there is no known interaction problem. But if you start both in the same week you will never know which one worked.

With food or on an empty stomach?

In the trials it was mostly taken with food, and in practice that lowers the chance of nausea. Taking it on an empty stomach offers no demonstrated advantage.

References

1. Chandrasekhar, K., Kapoor, J., & Anishetty, S. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 34(3), 255-262. https://pubmed.ncbi.nlm.nih.gov/23439798/
2. Salve, J., Pate, S., Debnath, K., & Langade, D. (2019). Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. Cureus, 11(12), e6466. https://pubmed.ncbi.nlm.nih.gov/32021735/
3. Langade, D., Kanchi, S., Salve, J., Debnath, K., & Ambegaokar, D. (2019). Efficacy and safety of ashwagandha root extract in insomnia and anxiety: a double-blind, randomized, placebo-controlled study. Cureus, 11(9), e5797. https://pubmed.ncbi.nlm.nih.gov/31728244/
4. Wankhede, S., Langade, D., Joshi, K., Sinha, S. R., & Bhattacharyya, S. (2015). Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. Journal of the International Society of Sports Nutrition, 12, 43. https://pubmed.ncbi.nlm.nih.gov/26609282/
5. Lopresti, A. L., Smith, S. J., Malvi, H., & Kodgule, R. (2019). An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study. Medicine, 98(37), e17186. https://pubmed.ncbi.nlm.nih.gov/31517876/
6. Bjornsson, H. K., Bjornsson, E. S., Avula, B., Khan, I. A., Jonasson, J. G., Ghabril, M., Hayashi, P. H., & Navarro, V. (2020). Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network. Liver International, 40(4), 825-829.